Funder
National Natural Science Foundation of China
Shanghai Education Commission
Shanghai City Science and Technology Commission
Subject
Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The combination treatment of oncolytic adenovirus H101 with nivolumab for refractory advanced hepatocellular carcinoma: an open-label, single-arm, pilot study;ESMO Open;2024-02
2. Malignant ascites: Current therapy options and treatment prospects;Cancer Treatment Reviews;2023-12
3. Recombinant Human Adenovirus Type 5 (H101) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Genomic Profiling Relating to Clinical Efficacy;Drug Design, Development and Therapy;2023-11
4. Effectiveness and safety of human type 5 recombinant adenovirus (H101) in malignant tumor with malignant pleural effusion and ascites: A multicenter, observational, real‐world study;Thoracic Cancer;2023-09-07
5. Malignant ascites in pancreatic cancer: Pathophysiology, diagnosis, molecular characterization, and therapeutic strategies;Frontiers in Oncology;2023-03-16